Home > Annual Financials > GUFIC BIOSCIENCES

GUFIC BIOSCIENCES Financial Statement Analysis
[BOM: 509079|NSE : GUFICBIO]

The Revenues of GUFIC BIOSCIENCES have decreased by -11.36% YoY .
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has increased by 4.50 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

GUFIC BIOSCIENCES Last 5 Annual Financial Results
[BOM: 509079|NSE : GUFICBIO]

StandaloneMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹691 Cr₹779 Cr₹488 Cr₹379 Cr₹351 Cr
Expenses ₹556 Cr₹631 Cr₹404 Cr₹327 Cr₹305 Cr
Operating Profit (Excl OI) ₹135 Cr₹148 Cr₹84 Cr₹52 Cr₹46 Cr
Other Income ₹2.57 Cr₹3.10 Cr₹3.73 Cr₹5.79 Cr₹4.17 Cr
Interest ₹8.22 Cr₹5.37 Cr₹14 Cr₹14 Cr₹10 Cr
Depreciation ₹22 Cr₹19 Cr₹16 Cr₹14 Cr₹4.65 Cr
Profit Before Tax ₹107 Cr₹127 Cr₹58 Cr₹30 Cr₹35 Cr
Profit After Tax ₹80 Cr₹96 Cr₹44 Cr₹23 Cr₹22 Cr
Earnings Per Share (Rs)₹8.59₹8.22₹9.89₹4.56₹2.34
PAT Margin (%)9.169.9511.308.535.80
ROE(%)19.5725.8443.3129.2222.17
ROCE(%)17.3723.2347.2930.0521.01
Total Debt/Equity(x)0.600.900.230.320.90

Key Financials

Market Cap : ₹ 4,076.2 Cr
Revenue (TTM) : ₹ 803.8 Cr
Net Profit(TTM) : ₹ 84.9 Cr
EPS (TTM) : ₹ 8.5
P/E (TTM) : 48.0

Industry Peers & Returns1W1M1Y
GUFIC BIOSCIENCES -7.6% -11.2% 20.9%
SUN PHARMACEUTICAL INDUSTRIES -5.1% -9.4% 29.2%
CIPLA -1.4% -6.7% -1.5%
DR REDDYS LABORATORIES -9% -14.4% 1.4%
ZYDUS LIFESCIENCES -7% -5% 22.6%
DIVIS LABORATORIES -7.3% -10.9% 53%
MANKIND PHARMA -2.2% -13.9% 19.3%
TORRENT PHARMACEUTICALS 4.7% -1.7% 32.9%
LUPIN -5.4% -12.4% 43.4%


GUFIC BIOSCIENCES Revenues
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-11.36 %

5 Yr CAGR

18.46 %

Years Revenues % Change
Mar2024 ₹691 Cr
-11.36
Mar2023 ₹779 Cr
59.76
Mar2022 ₹488 Cr
28.74
Mar2021 ₹379 Cr
8.00
Mar2020 ₹351 Cr -


GUFIC BIOSCIENCES Operating Profit
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-9.04 %

5 Yr CAGR

30.81 %

Years Operating Profit % Change
Mar2024 ₹135 Cr
-9.04
Mar2023 ₹148 Cr
76.39
Mar2022 ₹84 Cr
61.03
Mar2021 ₹52 Cr
13.33
Mar2020 ₹46 Cr -

Operating Margins
Y-o-Y

2.63 %

5 Yr CAGR

10.44 %

Years Operating Margin% % Change
Mar2024 19.5%
2.63
Mar2023 19%
10.40
Mar2022 17.21%
25.07
Mar2021 13.76%
4.96
Mar2020 13.11% -

GUFIC BIOSCIENCES Profit After Tax
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-16.84 %

5 Yr CAGR

38.06 %

Years Profit After Tax % Change
Mar2024 ₹80 Cr
-16.84
Mar2023 ₹96 Cr
116.68
Mar2022 ₹44 Cr
94.96
Mar2021 ₹23 Cr
3.40
Mar2020 ₹22 Cr -

PAT Margins
Y-o-Y

-7.94 %

5 Yr CAGR

12.10 %

Years PAT Margin(%) % Change
Mar2024 9.16 %
-7.94
Mar2023 9.95 %
-11.95
Mar2022 11.3 %
32.47
Mar2021 8.53 %
47.07
Mar2020 5.8 % -

GUFIC BIOSCIENCES Earnings Per Share (EPS)
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

4.50 %

5 Yr CAGR

38.42 %

Years EPS % Change
Mar2024 ₹8.59
4.50
Mar2023 ₹8.22
-16.89
Mar2022 ₹9.89
116.89
Mar2021 ₹4.56
94.87
Mar2020 ₹2.34 -

GUFIC BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-25.23 %

5 Yr CAGR

-4.65 %

Years ROCE % Change
Mar2024 17.37%
-25.23
Mar2023 23.23%
-50.88
Mar2022 47.29%
57.37
Mar2021 30.05%
43.03
Mar2020 21.01% -

GUFIC BIOSCIENCES Share Price vs Sensex

Current Share Price : ₹406.4
Current MarketCap: ₹ 4,076.2 Cr
Updated EOD on :Jan 28,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
GUFIC BIOSCIENCES

-7.6%

-11.2%

20.9%

SENSEX

0.1%

-3.6%

7.9%

GUFIC BIOSCIENCES related INDICES

BSE Indices1W1M1Y
S&P BSE ALLCAP -0.3% -3.5% 35.8%
S&P BSE HEALTHCARE -5.4% -9.8% 22%
S&P BSE MIDSMALLCAP -7.1% -11.2% 8.4%
S&P BSE SMALL CAP -8.2% -13.7% 9.5%
No NSE index found

You may also like the below Video Courses


FAQ about GUFIC BIOSCIENCES Financials


How the annual revenues of GUFIC BIOSCIENCES have changed ?

The Revenues of GUFIC BIOSCIENCES have decreased by -11.36% YoY .

How the Earnings per Share (EPS) of GUFIC BIOSCIENCES have changed?

The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has increased by 4.50 % YoY .